DE69407006D1 - Tripeptid mit antithrombischer Wirkung - Google Patents

Tripeptid mit antithrombischer Wirkung

Info

Publication number
DE69407006D1
DE69407006D1 DE69407006T DE69407006T DE69407006D1 DE 69407006 D1 DE69407006 D1 DE 69407006D1 DE 69407006 T DE69407006 T DE 69407006T DE 69407006 T DE69407006 T DE 69407006T DE 69407006 D1 DE69407006 D1 DE 69407006D1
Authority
DE
Germany
Prior art keywords
antithrombic
tripeptide
effects
inhibitors
perhydroisoquinolin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69407006T
Other languages
English (en)
Other versions
DE69407006T2 (de
Inventor
Paul David Gesellchen
Robert Theodore Shuman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of DE69407006D1 publication Critical patent/DE69407006D1/de
Application granted granted Critical
Publication of DE69407006T2 publication Critical patent/DE69407006T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0821Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0823Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06078Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0804Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0812Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0821Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE69407006T 1993-09-14 1994-09-12 Tripeptid mit antithrombischer Wirkung Expired - Fee Related DE69407006T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/121,134 US5430023A (en) 1990-09-28 1993-09-14 Tripeptide antithrombotic agents

Publications (2)

Publication Number Publication Date
DE69407006D1 true DE69407006D1 (de) 1998-01-08
DE69407006T2 DE69407006T2 (de) 1998-04-16

Family

ID=22394776

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69407006T Expired - Fee Related DE69407006T2 (de) 1993-09-14 1994-09-12 Tripeptid mit antithrombischer Wirkung

Country Status (31)

Country Link
US (1) US5430023A (de)
EP (1) EP0643073B1 (de)
JP (1) JPH07149791A (de)
KR (1) KR100312388B1 (de)
CN (1) CN1055698C (de)
AT (1) ATE160574T1 (de)
AU (1) AU674773B2 (de)
BR (1) BR9403542A (de)
CA (1) CA2131982C (de)
CO (1) CO4290364A1 (de)
CY (1) CY2072B1 (de)
CZ (1) CZ286139B6 (de)
DE (1) DE69407006T2 (de)
DK (1) DK0643073T3 (de)
ES (1) ES2110186T3 (de)
FI (1) FI944231A (de)
GR (1) GR3026115T3 (de)
HU (1) HU220620B1 (de)
IL (1) IL110933A (de)
MY (1) MY112879A (de)
NO (1) NO310240B1 (de)
NZ (1) NZ264438A (de)
PE (1) PE43695A1 (de)
PH (1) PH31655A (de)
PL (1) PL176448B1 (de)
RU (1) RU2105010C1 (de)
SI (1) SI0643073T1 (de)
TW (1) TW275622B (de)
UA (1) UA32556C2 (de)
YU (1) YU54194A (de)
ZA (1) ZA947015B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69314478T2 (de) * 1992-03-04 1999-02-11 Gyogyszerkutato Intezet Neuartige antikoagulierende peptidderivate und arzneimittel die solche enthalten so wie entsprechendes herstellungsverfahren
US5602101A (en) * 1994-03-04 1997-02-11 Eli Lilly And Company Antithrombotic agents
US5885967A (en) * 1994-03-04 1999-03-23 Eli Lilly And Company Antithrombotic agents
US5726159A (en) * 1994-03-04 1998-03-10 Eli Lilly And Company Antithrombotic agents
US5707966A (en) * 1994-03-04 1998-01-13 Eli Lilly And Company Antithrombotic agents
CA2143533A1 (en) * 1994-03-04 1995-09-05 Kenneth D. Kurz Antithrombotic agents
AU1884395A (en) * 1994-03-04 1995-09-18 Eli Lilly And Company Antithrombotic agents
ZA951618B (en) * 1994-03-04 1996-08-27 Lilly Co Eli Antithrombotic agents
US5705487A (en) * 1994-03-04 1998-01-06 Eli Lilly And Company Antithrombotic agents
US5691356A (en) * 1994-03-21 1997-11-25 Bristol-Myers Squibb Company Disubstituted heterocyclic thrombin inhibitors
US5710130A (en) * 1995-02-27 1998-01-20 Eli Lilly And Company Antithrombotic agents
US5914319A (en) * 1995-02-27 1999-06-22 Eli Lilly And Company Antithrombotic agents
US6046169A (en) * 1995-06-07 2000-04-04 Cor Therapeutics, Inc. Inhibitors of factor XA
US5919765A (en) * 1995-06-07 1999-07-06 Cor Therapeutics, Inc. Inhibitors of factor XA
US5721214A (en) * 1995-06-07 1998-02-24 Cor Therapeutics, Inc. Inhibitors of factor Xa
US6069130A (en) 1995-06-07 2000-05-30 Cor Therapeutics, Inc. Ketoheterocyclic inhibitors of factor Xa
US6022861A (en) * 1995-06-07 2000-02-08 Cor Therapeutics, Inc. Ketoheterocyclic inhibitors of factor Xa
US6245743B1 (en) 1996-06-05 2001-06-12 Cor Therapeutics, Inc. Inhibitors of factor Xa
JP3539607B2 (ja) * 1997-02-19 2004-07-07 シャープ株式会社 空気調和機の運転制御システム
CA2289625A1 (en) 1997-05-15 1998-11-19 Charles Van Jackson Antithrombotic compound
US6903075B1 (en) 1997-05-29 2005-06-07 Merck & Co., Inc. Heterocyclic amide compounds as cell adhesion inhibitors
WO1999064395A1 (en) * 1998-06-11 1999-12-16 Merck & Co., Inc. Heterocyclic amide compounds as cell adhesion inhibitors
SE9802973D0 (sv) * 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
US6172081B1 (en) 1999-06-24 2001-01-09 Novartis Ag Tetrahydroisoquinoline 3-carboxamide derivatives
CN1326496C (zh) * 2002-02-11 2007-07-18 黄金-T技术股份有限公司 预防血栓形成的装置
US7205315B2 (en) 2003-09-27 2007-04-17 Sanofi-Aventis Deutschland Gmbh Bicyclic imino acid derivatives as inhibitors of matrix metalloproteinases
CN102391360B (zh) * 2011-11-02 2013-07-03 东南大学 一种抗血栓和血小板聚集的小肽
KR102388531B1 (ko) * 2021-07-07 2022-04-21 이재호 특장차용 스마트 유압 시스템

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU177098B (en) * 1979-01-04 1981-07-28 Gyogyszerkutato Intezet Process for producing new peptidyl-n-carboxy-l-arginin-a
HU178398B (en) * 1979-06-12 1982-04-28 Gyogyszerkutato Intezet Process for producing new agmatine derivatives of activity against haemagglutination
HU184368B (en) * 1981-01-13 1984-08-28 Gyogyszerkutato Intezet Process for preparing d-phenyl-alanyl-l-propyl-l-arginine-ald ehyde-shulphate
HU192646B (en) * 1984-12-21 1987-06-29 Gyogyszerkutato Intezet Process for preparing new n-alkyl-peptide aldehydes
DE3827415A1 (de) * 1988-08-12 1990-02-15 Behringwerke Ag Peptidderivate, verfahren zu ihrer herstellung und ihre verwendung
IL99527A (en) * 1990-09-28 1997-08-14 Lilly Co Eli Tripeptide antithrombotic agents

Also Published As

Publication number Publication date
CZ286139B6 (cs) 2000-01-12
CA2131982A1 (en) 1995-03-15
ZA947015B (en) 1996-03-12
ATE160574T1 (de) 1997-12-15
GR3026115T3 (en) 1998-05-29
KR950008534A (ko) 1995-04-19
BR9403542A (pt) 1995-06-20
HUT67849A (en) 1995-05-29
EP0643073B1 (de) 1997-11-26
YU54194A (sh) 1997-01-08
US5430023A (en) 1995-07-04
MY112879A (en) 2001-10-31
PE43695A1 (es) 1995-12-09
NO943402D0 (no) 1994-09-13
NO310240B1 (no) 2001-06-11
PH31655A (en) 1999-01-12
RU94034734A (ru) 1996-07-20
SI0643073T1 (en) 1998-08-31
NO943402L (no) 1995-03-15
HU220620B1 (hu) 2002-03-28
TW275622B (de) 1996-05-11
AU674773B2 (en) 1997-01-09
AU7294894A (en) 1995-03-30
RU2105010C1 (ru) 1998-02-20
HU9402626D0 (en) 1994-11-28
IL110933A (en) 1998-12-27
ES2110186T3 (es) 1998-02-01
FI944231A0 (fi) 1994-09-13
PL305009A1 (en) 1995-03-20
DK0643073T3 (da) 1997-12-29
NZ264438A (en) 1996-06-25
CN1106819A (zh) 1995-08-16
IL110933A0 (en) 1994-11-28
DE69407006T2 (de) 1998-04-16
FI944231A (fi) 1995-03-15
UA32556C2 (uk) 2001-02-15
CN1055698C (zh) 2000-08-23
EP0643073A1 (de) 1995-03-15
JPH07149791A (ja) 1995-06-13
KR100312388B1 (ko) 2001-12-28
CA2131982C (en) 2003-07-29
CZ222094A3 (en) 1995-03-15
PL176448B1 (pl) 1999-05-31
CO4290364A1 (es) 1996-04-17
CY2072B1 (en) 1998-09-11

Similar Documents

Publication Publication Date Title
DE69407006D1 (de) Tripeptid mit antithrombischer Wirkung
PT672658E (pt) Agentes antitromboticos
DE69228106D1 (de) HIV-Protease-Inhibitoren
DK0816376T3 (da) Thrombininhibitorer som antikoagulante midler
AU2406402A (en) Substituted benzene derivatives or salts thereof
DK0604183T3 (da) HIV-protease-inhibitorer anvendelige i behandlingen af AIDS
DE69628360D1 (de) Azepinonverbindungen zur Anwendung bei der Hemmung von ACE und NEP
FI930453A0 (fi) Tumoerhaemmande kompositioner och behandlingsmetoder
TH38361A (th) สารยับยั้งเซรีนโปรทีเอส

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee